Stuart A. Ross

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

Medicine, Endocrinology, Pharmacology +14

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text

Medicine, Endocrinology, Nephrology +15

MitoNEET is an iron-containing outer mitochondrial membrane protein that regulates oxidative capacity

Sandra E. Wiley, Anne N. Murphy, Stuart A. Ross et al. · Proceedings of the National Academy of Sciences · 2007 · 325 citations

Life Sciences, Biochemistry, Pharmacology +17

Phosphorylation of the Polymeric Immunoglobulin Receptor Required for Its Efficient Transcytosis

James E. Casanova, Philip P. Breitfeld, Stuart A. Ross et al. · Science · 1990 · 267 citations

Life Sciences, Biochemistry, Cell Biology +17

Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics with early nephropathy

Yves Lacourciére, André Bélanger, Chantal Godin et al. · Kidney International · 2000 · 229 citations · Full text

Medicine, Nephrology, Pharmacotherapy +13